Latest Breaking News On - Ultragenyx pharmaceutical - Page 6 : comparemela.com

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 1-year price […]

United statesThomas richard kassbergRobertw bairdAssociates corpCanaccord genuity groupCovestor ltdAllspring global investments holdingsUltragenyx pharmaceutical incJpmorgan chase coRoyal bankUltragenyx pharmaceuticalGet free reportGenuity groupRichard kassbergJohn richard pinionState retirement system